speb/financial-data huggingface dataset:
Financial ratios for CCLD — quarterly report dated 2025-03-31
Total revenue: 27632000
Gross profit: 12168000
Operating income: 2133000
Net income: 1948000
Capital expenditures: 624000
Operating cash flow: 5113000
Depreciation & amortization: 3407000
Net tangible assets: 18114000
Owner earnings: 4731000
Return on net tangible assets (%): 26.11791984100695
Capex to operating income (%): 29.254571026722925
Buffett classification: The Good
Stock price: 1.39
P/E ratio: 7.580236025410677
Shares outstanding: 42492949
Book value: 54177000
P/B ratio: 1.0902264634438967
Market cap (USD): 59065199.11
Debt to equity: 0.06067150266718349
Current ratio: 1.6884181957637618
Quick ratio: 1.6524868723818515
Effective tax rate (%): 2.0613373554550023
Interest coverage ratio: 36.775862068965516
COGS to revenue (%): 55.964099594672845
R&D to revenue (%): 4.4694557035321365
SG&A to revenue (%): 19.770555877243776
Free cash flow (dilution-adjusted): 3535000
Buyback yield (%): 0
Retained earnings: -64682000
Inventory turnover: 25.392446633825944
Receivables turnover: 1.5050108932461874
Capitalized R&D asset: 1235000
ROCI (R&D-adjusted, %): 5.111049640975993
FCF margin (%): 12.79313839027215
Rule of 40 score: 12.79313839027215
Financial ratios for CCLD — quarterly report dated 2025-06-30
Total revenue: 27377000
Gross profit: 12897000
Operating income: 3019000
Net income: 2902000
Capital expenditures: 1162000
Operating cash flow: 7408000
Depreciation & amortization: 3448000
Net tangible assets: 21372000
Owner earnings: 5188000
Return on net tangible assets (%): 24.27475201197829
Capex to operating income (%): 38.489566081483936
Buffett classification: The Good
Stock price: 2.36
P/E ratio: 20.676981369072163
Shares outstanding: 42492949
Book value: 56076000
P/B ratio: 1.7883472366074613
Market cap (USD): 100283359.64
Debt to equity: 0.060400171196233685
Current ratio: 1.9144088669950738
Quick ratio: 1.882204433497537
Effective tax rate (%): 1.4266304347826086
Interest coverage ratio: 44.39705882352941
COGS to revenue (%): 52.89111297804726
R&D to revenue (%): 3.725755195967418
SG&A to revenue (%): 20.00219162070351
Free cash flow (dilution-adjusted): 5304000
Buyback yield (%): 0
Retained earnings: -61780000
Inventory turnover: 27.68642447418738
Receivables turnover: 1.561366487966237
Capitalized R&D asset: 1847450
ROCI (R&D-adjusted, %): 5.4022267888987585
Rosenberg metric: 0.5902834008097166
FCF margin (%): 19.373927019030575
Revenue growth (%): -0.9228430804863926
Rule of 40 score: 18.451083938544183
Financial ratios for CCLD — quarterly report dated 2025-09-30
Total revenue: 31067000
Gross profit: 14843000
Operating income: 3227000
Net income: 3060000
Capital expenditures: 869000
Operating cash flow: 7365000
Depreciation & amortization: 4081000
Net tangible assets: 6136000
Owner earnings: 6272000
Return on net tangible assets (%): 102.21642764015645
Capex to operating income (%): 26.929036256585064
Buffett classification: The Good
Stock price: 3.21
P/E ratio: 17.244294094816688
Shares outstanding: 42492949
Book value: 57804000
P/B ratio: 2.3597392272161093
Market cap (USD): 136402366.29
Debt to equity: 0.16722026157359351
Current ratio: 1.2611075199310493
Quick ratio: 1.2350355526826116
Effective tax rate (%): 1.3857557202707058
Interest coverage ratio: 21.952380952380953
COGS to revenue (%): 52.22261563717127
R&D to revenue (%): 5.098657739723823
SG&A to revenue (%): 19.345285994785463
Free cash flow (dilution-adjusted): 5580000
Buyback yield (%): 0
Retained earnings: -58720000
Inventory turnover: 26.816528925619835
Receivables turnover: 1.610356624507568
Capitalized R&D asset: 2674950
ROCI (R&D-adjusted, %): 5.041452551265753
Rosenberg metric: 1.907843137254902
FCF margin (%): 17.9611806740271
Revenue growth (%): 13.478467326588012
Rule of 40 score: 31.439648000615115
Financial ratios for CCLD — annual report dated 2025-12-31
Total revenue: 120499000
Gross profit: 56043000
Operating income: 11497000
Net income: 10798000
Capital expenditures: 4778000
Operating cash flow: 28561000
Depreciation & amortization: 16975000
Net tangible assets: 9096000
Owner earnings: 22995000
Return on net tangible assets (%): 252.8034300791557
Capex to operating income (%): 41.55866747847264
Buffett classification: The Good
Stock price: 2.92
P/E ratio: 11.490962315243562
Shares outstanding: 42492949
Book value: 59506000
P/B ratio: 2.0851579854132356
Market cap (USD): 124079411.08
Debt to equity: 0.07197593519981178
Current ratio: 1.0538426892683126
Quick ratio: 1.0330835687671458
Effective tax rate (%): 1.8095844321178505
Interest coverage ratio: 40.059233449477354
COGS to revenue (%): 53.4909003394219
R&D to revenue (%): 5.296309512942017
SG&A to revenue (%): 19.256591341006978
Free cash flow (dilution-adjusted): 20080000
Buyback yield (%): 0
Retained earnings: -55832000
Inventory turnover: 127.13214990138067
Receivables turnover: 6.429356525450859
Capitalized R&D asset: 10478150
ROCI (R&D-adjusted, %): 17.531723580955692
Rosenberg metric: 1.5995768315260512
FCF margin (%): 16.6640387057154
Revenue growth (%): 8.717305592897679
Rule of 40 score: 25.38134429861308
Financial ratios for CCLD — quarterly report dated 2025-12-31
Total revenue: 34423000
Gross profit: 16135000
Operating income: 3118000
Net income: 2888000
Capital expenditures: 2123000
Operating cash flow: 8675000
Depreciation & amortization: 6039000
Net tangible assets: 9096000
Owner earnings: 6804000
Return on net tangible assets (%): 74.80211081794195
Capex to operating income (%): 68.08851828094933
Buffett classification: The Good
Stock price: 2.92
P/E ratio: 11.490962315243562
Shares outstanding: 42492949
Book value: 59506000
P/B ratio: 2.0851579854132356
Market cap (USD): 124079411.08
Debt to equity: 0.07197593519981178
Current ratio: 1.0538426892683126
Quick ratio: 1.0330835687671458
Effective tax rate (%): 2.465383316447146
Interest coverage ratio: 222.71428571428572
COGS to revenue (%): 53.12726955814426
R&D to revenue (%): 7.387502541905122
SG&A to revenue (%): 18.170990326235366
Free cash flow (dilution-adjusted): 5661000
Buyback yield (%): 0
Retained earnings: -55832000
Inventory turnover: 36.071005917159766
Receivables turnover: 1.8366769821790632
Capitalized R&D asset: 3940880
ROCI (R&D-adjusted, %): 5.87839023094584
Rosenberg metric: 0.8156565656565656
FCF margin (%): 16.445399877988553
Revenue growth (%): 10.802459201081534
Rule of 40 score: 27.24785907907009
Financial ratios for CDXS — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 5947000
Buffett classification: The Gruesome
Stock price: 31.27
Shares outstanding: 90896567
Market cap (USD): 2842335650.09
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDXS — annual report dated 2022-12-31
Total revenue: 138590000
Gross profit: 100557000
Operating income: -31714000
Net income: -33592000
Capital expenditures: 8278000
Operating cash flow: 11284000
Depreciation & amortization: 10251000
Net tangible assets: 141556000
Owner earnings: -31619000
Return on net tangible assets (%): -22.336743055751786
Buffett classification: The Gruesome
Stock price: 4.66
Shares outstanding: 90896567
Book value: 144797000
P/B ratio: 2.925323053792551
Market cap (USD): 423578002.22
Debt to equity: 0.30137364724407273
Current ratio: 3.3198956507561244
Quick ratio: 3.2785431867280805
COGS to revenue (%): 27.442816942059313
R&D to revenue (%): 57.79565625225486
SG&A to revenue (%): 37.64485172090338
Free cash flow (dilution-adjusted): -11554000
Buyback yield (%): 0
Retained earnings: -421290000
Inventory turnover: 18.744701823558405
Receivables turnover: 3.390746947862892
Capitalized R&D asset: 80099000
ROCI (R&D-adjusted, %): 7.705518798310508
FCF margin (%): -8.336820838444332
Rule of 40 score: -8.336820838444332
Financial ratios for CDXS — annual report dated 2023-12-31
Total revenue: 70143000
Gross profit: 57334000
Operating income: -54801000
Net income: -76240000
Capital expenditures: 3667000
Operating cash flow: -52638000
Depreciation & amortization: 9923000
Net tangible assets: 84152000
Owner earnings: -69984000
Return on net tangible assets (%): -83.16379884019393
Buffett classification: The Gruesome
Stock price: 3.05
Shares outstanding: 90896567
Book value: 86615000
P/B ratio: 3.200768104254459
Market cap (USD): 277234529.34999996
Debt to equity: 0.18500259770247648
Current ratio: 2.608596148478928
Quick ratio: 2.533658945018141
Interest coverage ratio: -4.464803649991853
COGS to revenue (%): 18.26126627033346
R&D to revenue (%): 83.94993085553797
SG&A to revenue (%): 75.91634232924169
Free cash flow (dilution-adjusted): -67027000
Buyback yield (%): 0
Retained earnings: -497530000
Inventory turnover: 4.770577281191806
Receivables turnover: 3.519821356884785
Capitalized R&D asset: 112551330
ROCI (R&D-adjusted, %): -19.806610327259648
Rosenberg metric: -0.5396197205957628
FCF margin (%): -95.55764652210485
Revenue growth (%): -49.38812324121509
Rule of 40 score: -144.94576976331993
Financial ratios for CDXS — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 2024000
Buffett classification: The Gruesome
Stock price: 3.08
Shares outstanding: 90896567
Market cap (USD): 279961426.36
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDXS — annual report dated 2024-12-31
Total revenue: 59345000
Gross profit: 43057000
Operating income: -58354000
Net income: -65276000
Capital expenditures: 4218000
Operating cash flow: -49410000
Depreciation & amortization: 4946000
Net tangible assets: 64464000
Owner earnings: -64548000
Return on net tangible assets (%): -100.13030528667164
Buffett classification: The Gruesome
Stock price: 4.77
Shares outstanding: 90896567
Book value: 66927000
P/B ratio: 6.4783514066071985
Market cap (USD): 433576624.59
Debt to equity: 0.8949302971894751
Current ratio: 4.176759133964818
Quick ratio: 4.100685047361299
Interest coverage ratio: -5.614740690849611
COGS to revenue (%): 27.44628865110793
R&D to revenue (%): 77.95601988373073
SG&A to revenue (%): 92.9277950964698
Free cash flow (dilution-adjusted): -66802000
Buyback yield (%): 0
Retained earnings: -562806000
Inventory turnover: 9.053918843802112
Receivables turnover: 3.1426074984113535
Capitalized R&D asset: 112148620
ROCI (R&D-adjusted, %): -31.08900524530126
Rosenberg metric: -0.24245563386261357
FCF margin (%): -112.56550678237424
Revenue growth (%): -15.39426599945825
Rule of 40 score: -127.9597727818325
Financial ratios for CDXS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.77
Shares outstanding: 90896567
Market cap (USD): 433576624.59
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDXS — quarterly report dated 2025-03-31
Total revenue: 7543000
Gross profit: 4811000
Operating income: -20486000
Net income: -20688000
Capital expenditures: 1255000
Operating cash flow: -13798000
Depreciation & amortization: 1909000
Net tangible assets: 47166000
Owner earnings: -20034000
Return on net tangible assets (%): -42.47551202137132
Buffett classification: The Gruesome
Stock price: 2.69
Shares outstanding: 90896567
Book value: 49629000
P/B ratio: 4.926792101996816
Market cap (USD): 244511765.23
Debt to equity: 1.1988353583590239
Current ratio: 3.7226926941294676
Quick ratio: 3.6374814602172143
Interest coverage ratio: -21.747346072186836
COGS to revenue (%): 36.219011003579475
R&D to revenue (%): 171.57629590348668
SG&A to revenue (%): 163.7942463210924
Free cash flow (dilution-adjusted): -17432000
Buyback yield (%): 0
Retained earnings: -583494000
Inventory turnover: 1.5339696799550815
Receivables turnover: 0.6509881764045914
Capitalized R&D asset: 12942000
ROCI (R&D-adjusted, %): -9.805834876951575
FCF margin (%): -231.10168368023332
Rule of 40 score: -231.10168368023332
Financial ratios for CDXS — quarterly report dated 2025-06-30
Total revenue: 15328000
Gross profit: 13230000
Operating income: -12862000
Net income: -13272000
Capital expenditures: 2510000
Operating cash flow: -17967000
Depreciation & amortization: 2066000
Net tangible assets: 53168000
Owner earnings: -13716000
Return on net tangible assets (%): -25.79747216370749
Buffett classification: The Gruesome
Stock price: 2.44
Shares outstanding: 90896567
Book value: 55631000
P/B ratio: 3.9867631982168215
Market cap (USD): 221787623.48
Debt to equity: 1.239956139562474
Current ratio: 5.823259171752969
Quick ratio: 5.695609371923607
Interest coverage ratio: -13.071138211382113
COGS to revenue (%): 13.687369519832984
R&D to revenue (%): 89.86821503131523
SG&A to revenue (%): 80.3562108559499
Free cash flow (dilution-adjusted): -23013000
Buyback yield (%): 0
Retained earnings: -596766000
Inventory turnover: 1.07866323907455
Receivables turnover: 0.929927804404538
Capitalized R&D asset: 22446140
ROCI (R&D-adjusted, %): -5.494935872782953
Rosenberg metric: 0.6505176943285428
FCF margin (%): -150.13700417536535
Revenue growth (%): 103.20827257059526
Rule of 40 score: -46.92873160477009
Financial ratios for CDXS — quarterly report dated 2025-09-30
Total revenue: 8601000
Gross profit: 6136000
Operating income: -18949000
Net income: -19615000
Capital expenditures: 181000
Operating cash flow: -7703000
Depreciation & amortization: 2094000
Net tangible assets: 36081000
Owner earnings: -17702000
Return on net tangible assets (%): -49.06183309775228
Buffett classification: The Gruesome
Stock price: 2.44
Shares outstanding: 90896567
Book value: 38544000
P/B ratio: 5.7541413314653385
Market cap (USD): 221787623.48
Debt to equity: 1.7803289746782898
Current ratio: 4.124059539918809
Quick ratio: 4.019269282814614
Interest coverage ratio: -14.66640866873065
COGS to revenue (%): 28.659458202534587
R&D to revenue (%): 161.23706545750494
SG&A to revenue (%): 130.41506801534706
Free cash flow (dilution-adjusted): -10398000
Buyback yield (%): 0
Retained earnings: -616381000
Inventory turnover: 1.2732438016528926
Receivables turnover: 0.8836946470769547
Capitalized R&D asset: 27368110
ROCI (R&D-adjusted, %): -14.007344848671476
Rosenberg metric: -0.5149909255898366
FCF margin (%): -120.89291942797348
Revenue growth (%): -43.88700417536535
Rule of 40 score: -164.77992360333883
Financial ratios for CDXS — annual report dated 2025-12-31
Total revenue: 70387000
Gross profit: 61049000
Operating income: -38332000
Net income: -43974000
Capital expenditures: 4466000
Operating cash flow: -19376000
Depreciation & amortization: 5248000
Net tangible assets: 48066000
Owner earnings: -43192000
Return on net tangible assets (%): -89.85977614113926
Buffett classification: The Gruesome
Stock price: 1.63
Shares outstanding: 90896567
Book value: 50529000
P/B ratio: 2.9322053515802806
Market cap (USD): 148161404.20999998
Debt to equity: 1.448831364167112
Current ratio: 3.824149780779713
Quick ratio: 3.7523798238337878
Interest coverage ratio: -7.9642634531477245
COGS to revenue (%): 13.266654353786922
R&D to revenue (%): 74.31343856109794
SG&A to revenue (%): 66.87882705613252
Free cash flow (dilution-adjusted): -33471000
Buyback yield (%): 0
Retained earnings: -606780000
Inventory turnover: 5.139240506329114
Receivables turnover: 6.586842597791503
Capitalized R&D asset: 102735260
ROCI (R&D-adjusted, %): -17.099196564211503
Rosenberg metric: 0.38890690184380605
FCF margin (%): -47.55281515052496
Revenue growth (%): 18.60645378717668
Rule of 40 score: -28.946361363348277
Financial ratios for CDXS — quarterly report dated 2025-12-31
Total revenue: 38915000
Gross profit: 36872000
Operating income: 13966000
Net income: 9601000
Capital expenditures: 520000
Operating cash flow: 20092000
Depreciation & amortization: -821000
Net tangible assets: 48066000
Owner earnings: 8260000
Return on net tangible assets (%): 17.184704364831692
Capex to operating income (%): 3.7233280824860375
Buffett classification: The Great
Stock price: 1.63
P/E ratio: 3.85796802963233
Shares outstanding: 90896567
Book value: 50529000
P/B ratio: 2.9322053515802806
Market cap (USD): 148161404.20999998
Debt to equity: 1.448831364167112
Current ratio: 3.824149780779713
Quick ratio: 3.7523798238337878
Effective tax rate (%): 0.18712963925563988
Interest coverage ratio: 8.75062656641604
COGS to revenue (%): 5.249903636130027
R&D to revenue (%): 30.11949119876654
SG&A to revenue (%): 28.742130283952207
Free cash flow (dilution-adjusted): 17372000
Buyback yield (%): 0
Retained earnings: -606780000
Inventory turnover: 1.124380847550908
Receivables turnover: 3.641680703724499
Capitalized R&D asset: 25558310
ROCI (R&D-adjusted, %): 8.488118154460603
Rosenberg metric: 2.2163253533314102
FCF margin (%): 44.64088397790055
Revenue growth (%): 352.4473898383909
Rule of 40 score: 397.08827381629146
Financial ratios for CORA.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0012162162162162162
Shares outstanding: 765296805
Market cap (USD): 930766.3844594595
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CORA.L — annual report dated 2022-12-31
Total revenue: 0
Operating income: -1291566.265060241
Net income: -3028915.6626506024
Capital expenditures: 3932530.120481928
Operating cash flow: -1989156.6265060243
Net tangible assets: 29138554.216867473
Owner earnings: -6961445.783132531
Return on net tangible assets (%): -23.890841430638826
Buffett classification: The Gruesome
Stock price: 0.0004819277108433735
Shares outstanding: 765296805
Book value: 29138554.216867473
P/B ratio: 0.012657379450072358
Market cap (USD): 368817.7373493976
Debt to equity: 0
Current ratio: 2.8601036269430047
Quick ratio: 2.8601036269430047
Free cash flow (dilution-adjusted): -6055421.686746988
Buyback yield (%): 0
Retained earnings: -4839759.036144579
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.432499483150713
Rule of 40 score: 0
Financial ratios for CORA.L — annual report dated 2023-12-31
Total revenue: 0
Operating income: -1510126.582278481
Net income: -3739240.5063291136
Capital expenditures: 2260759.493670886
Operating cash flow: -483544.3037974683
Net tangible assets: 31208860.759493668
Owner earnings: -6000000
Return on net tangible assets (%): -19.225309267896982
Buffett classification: The Gruesome
Stock price: 0.00025316455696202533
Shares outstanding: 765296805
Book value: 31208860.75949367
P/B ratio: 0.006208045467450821
Market cap (USD): 193746.0265822785
Debt to equity: 0.6433583451632529
Current ratio: 1.0508811119384462
Quick ratio: 1.0508811119384462
Interest coverage ratio: -1.8553654743390358
Free cash flow (dilution-adjusted): -2851898.734177215
Buyback yield (%): 0
Retained earnings: -8716455.696202531
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.8387750963293445
Rule of 40 score: 0
Financial ratios for CORA.L — annual report dated 2024-12-31
Total revenue: 0
Operating income: -1558750
Net income: -1368750
Capital expenditures: 1681250
Operating cash flow: -1250000
Net tangible assets: 32348750
Owner earnings: -3050000
Return on net tangible assets (%): -9.428494145832527
Buffett classification: The Gruesome
Stock price: 0.00025
Shares outstanding: 765296805
Book value: 32348750
P/B ratio: 0.005914423316202326
Market cap (USD): 191324.20125
Debt to equity: 0
Current ratio: 4.236111111111111
Quick ratio: 4.236111111111111
Interest coverage ratio: -33.7027027027027
Free cash flow (dilution-adjusted): -2990000
Buyback yield (%): 0
Retained earnings: -9917500
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.818578770431624
Rule of 40 score: 0
Financial ratios for CORA.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 32348750
Buffett classification: The Gruesome
Stock price: 0.00025
Shares outstanding: 765296805
Book value: 32348750
P/B ratio: 0.005914423316202326
Market cap (USD): 191324.20125
Debt to equity: 0
Current ratio: 4.236111111111111
Quick ratio: 4.236111111111111
Buyback yield (%): 0
Retained earnings: -9917500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CORA.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 37441095.89041096
Buffett classification: The Gruesome
Stock price: 0.0009589041095890413
Shares outstanding: 765296805
Book value: 37441095.89041096
P/B ratio: 0.01960002061685936
Market cap (USD): 733846.2513698632
Debt to equity: 0
Current ratio: 5.890070921985815
Quick ratio: 5.890070921985815
Buyback yield (%): 0
Retained earnings: -11612328.767123288
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DABUR.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.681260714756693
Shares outstanding: 1773952388
Market cap (USD): 11852238399.793222
Buyback yield (%): 0
Retained earnings: 970731900.30331
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DABUR.NS — annual report dated 2023-03-31
Total revenue: 1391779537.1498175
Gross profit: 622462850.1827041
Operating income: 227589524.96954936
Net income: 207935444.57978076
Capital expenditures: 59160779.537149824
Operating cash flow: 181294762.48477468
Depreciation & amortization: 37875761.26674787
Net tangible assets: 934868453.1059684
Owner earnings: 186650426.3093788
Return on net tangible assets (%): 19.965421411885185
Capex to operating income (%): 25.994508993797194
Buffett classification: The Good
Stock price: 6.329719853836784
P/E ratio: 54.000517674015754
Shares outstanding: 1773952388
Book value: 1149991473.812424
P/B ratio: 9.764091217876528
Market cap (USD): 11228621650.084774
Debt to equity: 0.12432332813991101
Current ratio: 1.1771831009328342
Quick ratio: 0.6163743305729714
Effective tax rate (%): 23.317918762507436
Interest coverage ratio: 27.025021695111374
COGS to revenue (%): 55.27575786482487
SG&A to revenue (%): 10.35451769612944
Free cash flow (dilution-adjusted): 113046285.01827042
Buyback yield (%): 0
Retained earnings: 989686967.1132766
Inventory turnover: 3.1202894970852686
Receivables turnover: 13.46275110456554
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.601504837261352
FCF margin (%): 8.122427582875261
Rule of 40 score: 8.122427582875261
Financial ratios for DABUR.NS — annual report dated 2024-03-31
Total revenue: 1470398129.272095
Gross profit: 691358676.1002518
Operating income: 242086581.1248351
Net income: 220971339.48914737
Capital expenditures: 67259863.2929608
Operating cash flow: 241452212.49550307
Depreciation & amortization: 47872646.600311786
Net tangible assets: 1035441899.5083343
Owner earnings: 201584122.7964984
Return on net tangible assets (%): 19.46841468287288
Capex to operating income (%): 27.78339178505618
Buffett classification: The Good
Stock price: 6.0443857965451055
P/E ratio: 48.52417803396212
Shares outstanding: 1773952388
Book value: 1235529439.980813
P/B ratio: 8.678427458548446
Market cap (USD): 10722452617.774471
Debt to equity: 0.1324933903259996
Current ratio: 1.4450378202893832
Quick ratio: 0.9496798060263129
Effective tax rate (%): 23.20857746084774
Interest coverage ratio: 18.322381557451443
COGS to revenue (%): 52.9815318493025
SG&A to revenue (%): 12.409667540665408
Free cash flow (dilution-adjusted): 167787504.49694207
Buyback yield (%): 0
Retained earnings: 1077143542.391174
Inventory turnover: 3.336676990400469
Receivables turnover: 13.643459586968133
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.03712390270053
FCF margin (%): 11.411025432955597
Revenue growth (%): 5.6487820106392785
Rule of 40 score: 17.059807443594877
Financial ratios for DABUR.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 1096476349.7372193
Buffett classification: The Gruesome
Stock price: 7.223244147157191
Shares outstanding: 1773952388
Book value: 1288332537.0281892
P/B ratio: 9.94595016090644
Market cap (USD): 12813691203.956522
Debt to equity: 0.1623987568978817
Current ratio: 1.3947723767489586
Quick ratio: 0.9083576696055072
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DABUR.NS — quarterly report dated 2024-12-31
Total revenue: 391100361.34747636
Gross profit: 187948478.84368807
Operating income: 66820142.20771651
Net income: 60890546.68376267
Capital expenditures: 0
Depreciation & amortization: 12663480.592143606
Owner earnings: 73554027.27590628
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.745774565800209
P/E ratio: 41.84857530039626
Shares outstanding: 1773952388
Market cap (USD): 10192730511.910944
Effective tax rate (%): 21.557833267435143
Interest coverage ratio: 12.96945701357466
COGS to revenue (%): 51.94367036733477
SG&A to revenue (%): 6.75717159675136
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DABUR.NS — quarterly report dated 2025-03-31
Total revenue: 330855740.00467616
Gross profit: 154440028.05704933
Operating income: 36240355.389291555
Net income: 37424596.67991582
Capital expenditures: 0
Depreciation & amortization: 13662613.981762918
Net tangible assets: 1128337619.8269815
Owner earnings: 51087210.66167874
Return on net tangible assets (%): 4.527652873039225
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.746878282179951
P/E ratio: 68.10152517748784
Shares outstanding: 1773952388
Book value: 1310528407.7624502
P/B ratio: 7.779067124248388
Market cap (USD): 10194688452.218462
Debt to equity: 0.08475093351982915
Current ratio: 1.5126897676012634
Quick ratio: 0.9800645603504969
Effective tax rate (%): 24.07807530771285
Interest coverage ratio: 7.898089171974521
COGS to revenue (%): 53.3210371218385
SG&A to revenue (%): 6.232907206003943
Buyback yield (%): 0
Retained earnings: 1146580547.1124618
Inventory turnover: 0.6560816656594685
Receivables turnover: 3.1853010692177826
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.602015806826347
Revenue growth (%): -15.403877699124743
Rule of 40 score: -15.403877699124743
Financial ratios for DABUR.NS — annual report dated 2025-03-31
Total revenue: 1449615384.6153846
Gross profit: 679976619.1255553
Operating income: 220237315.87561372
Net income: 206643675.4734627
Capital expenditures: 63024316.10942249
Operating cash flow: 232259761.51508066
Depreciation & amortization: 52092588.26280102
Net tangible assets: 1128337619.8269815
Owner earnings: 195711947.62684125
Return on net tangible assets (%): 17.345158416046747
Capex to operating income (%): 28.616547499615162
Buffett classification: The Good
Stock price: 5.746878282179951
P/E ratio: 49.33462603614825
Shares outstanding: 1773952388
Book value: 1310528407.7624502
P/B ratio: 7.779067124248388
Market cap (USD): 10194688452.218462
Debt to equity: 0.08475093351982915
Current ratio: 1.5126897676012634
Quick ratio: 0.9800645603504969
Effective tax rate (%): 22.91829982860104
Interest coverage ratio: 12.82531145755327
COGS to revenue (%): 53.09261847369478
SG&A to revenue (%): 12.533135053923342
Free cash flow (dilution-adjusted): 164099836.33387887
Buyback yield (%): 0
Retained earnings: 1146580547.1124618
Inventory turnover: 2.862250066301177
Receivables turnover: 13.956117051209905
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.812785802058782
FCF margin (%): 11.320232806263865
Revenue growth (%): -1.4134093510441736
Rule of 40 score: 9.906823455219692
Financial ratios for DABUR.NS — quarterly report dated 2025-06-30
Total revenue: 398382869.1785631
Gross profit: 187376550.4329511
Operating income: 64788205.008190975
Net income: 60134565.8787737
Capital expenditures: 0
Depreciation & amortization: 13355956.002808332
Owner earnings: 73490521.88158202
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.520594430142758
P/E ratio: 61.80681377929225
Shares outstanding: 1773952388
Market cap (USD): 9793271672.531244
Effective tax rate (%): 23.290875614982948
Interest coverage ratio: 15.988449321397633
COGS to revenue (%): 52.96571089532336
SG&A to revenue (%): 5.9320092346192475
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 20.409840606946265
Rule of 40 score: 20.409840606946265
Financial ratios for DABUR.NS — quarterly report dated 2025-12-31
Total revenue: 396418625.3759608
Gross profit: 191795700.12253538
Operating income: 68724518.21321154
Net income: 62378300.10025621
Capital expenditures: 0
Depreciation & amortization: 13054472.540937953
Owner earnings: 75432772.64119416
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.538041662025176
P/E ratio: 44.488116613624854
Shares outstanding: 1773952388
Market cap (USD): 9824222231.19305
Effective tax rate (%): 22.14847210698767
Interest coverage ratio: 19.824550128534703
COGS to revenue (%): 51.61788880614839
SG&A to revenue (%): 6.6884914223090215
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -0.4930542838482039
Rule of 40 score: -0.4930542838482039
Financial ratios for DIACABS.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.20440458921271265
Shares outstanding: 526971060
Market cap (USD): 107715303.04628775
Buyback yield (%): 0
Retained earnings: -262858780.11341158
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIACABS.NS — annual report dated 2023-03-31
Total revenue: 1700816.077953715
Gross profit: -1305529.8416565165
Operating income: -5175359.317904994
Net income: -5222740.560292327
Capital expenditures: 167527.40560292327
Operating cash flow: 53819378.80633374
Depreciation & amortization: 2294384.8964677225
Net tangible assets: -119353057.24725945
Owner earnings: -3095883.0694275275
Buffett classification: The Gruesome
Stock price: 0.2375152253349574
Shares outstanding: 526971060
Book value: -119353057.24725944
Market cap (USD): 125163650.06090136
Debt to equity: -2.3915107288726496
Current ratio: 3.3576237815729275
Quick ratio: 1.7877496001089455
Interest coverage ratio: -70.35883424408014
COGS to revenue (%): 176.75902518673416
SG&A to revenue (%): 68.71746027199094
Free cash flow (dilution-adjusted): 53651851.40073082
Buyback yield (%): 21.118621891878774
Retained earnings: -249469500.6090134
Inventory turnover: 0.3628989453595379
Receivables turnover: 2.1236597569692637
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.116243296344215
FCF margin (%): 3154.4769652742466
Rule of 40 score: 3154.4769652742466
Financial ratios for DIACABS.NS — annual report dated 2024-03-31
Total revenue: 40203357.71675261
Gross profit: 7412795.299196546
Operating income: 2778438.6617100374
Net income: 2041611.704041252
Capital expenditures: 1964300.2758124475
Operating cash flow: 3148375.1049286486
Depreciation & amortization: 2345928.7684374624
Net tangible assets: -116721957.06919295
Owner earnings: 2423240.1966662663
Return on net tangible assets (%): -2.0760791349906564
Capex to operating income (%): 70.69798958971747
Buffett classification: The Good
Stock price: 0.6386756238003839
P/E ratio: 164.85190097805645
Shares outstanding: 526971060
Book value: -116721957.06919298
Market cap (USD): 336563570.47024953
Debt to equity: -2.4197395084412046
Current ratio: 1.3322022961227697
Quick ratio: 0.7191087691827783
Effective tax rate (%): -0.7175943728296172
Interest coverage ratio: 3.454819277108434
COGS to revenue (%): 81.5617507586744
SG&A to revenue (%): 5.263264647472169
Free cash flow (dilution-adjusted): 1184074.829116201
Buyback yield (%): 0
Retained earnings: -243568725.26681855
Inventory turnover: 2.273294491860084
Receivables turnover: 5.702899795702785
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7527141485215965
FCF margin (%): 2.9452137740793747
Revenue growth (%): 2263.768677746864
Rule of 40 score: 2266.7138915209434
Financial ratios for DIACABS.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -110241280.45867176
Buffett classification: The Gruesome
Stock price: 1.6665074056378406
Shares outstanding: 526971060
Book value: -110241280.45867178
Market cap (USD): 878201174.0468228
Debt to equity: -0.31466162480767973
Current ratio: 1.8905390508506579
Quick ratio: 0.9737073988406134
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIACABS.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.793332556241986
Shares outstanding: 526971060
Market cap (USD): 945034358.095349
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIACABS.NS — annual report dated 2025-03-31
Total revenue: 130394259.99532382
Gross profit: 20511035.772737898
Operating income: 5436123.451017068
Net income: 4032931.961655366
Capital expenditures: 7911339.724105681
Operating cash flow: 2005412.6724339488
Depreciation & amortization: 2370505.0268880054
Net tangible assets: -102719219.07879354
Owner earnings: -1507902.7355623106
Capex to operating income (%): 145.5327458140325
Buffett classification: The Gruesome
Stock price: 1.0448126969307971
P/E ratio: 136.52252496148887
Shares outstanding: 526971060
Book value: -102719219.07879356
Market cap (USD): 550586054.4030809
Debt to equity: -2.688181847772324
Current ratio: 1.1000758329724678
Quick ratio: 0.63188912030335
Effective tax rate (%): -0.24904103219807044
Interest coverage ratio: 3.6775938565203297
COGS to revenue (%): 84.26998567768744
SG&A to revenue (%): 2.916515934973563
Free cash flow (dilution-adjusted): -5905927.051671732
Buyback yield (%): 0
Retained earnings: -233413829.78723404
Inventory turnover: 4.5732594494812915
Receivables turnover: 6.351575205798343
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4491984500021404
FCF margin (%): -4.529284534367947
Revenue growth (%): 224.33674051306656
Rule of 40 score: 219.8074559786986
Financial ratios for DIACABS.NS — quarterly report dated 2025-03-31
Total revenue: 39023649.754500814
Gross profit: 5554079.9625906
Operating income: 966845.9200374093
Net income: 895955.1087210661
Capital expenditures: 0
Depreciation & amortization: 641197.1007715688
Net tangible assets: -102719219.07879354
Owner earnings: 1537152.209492635
Return on net tangible assets (%): -1.4964601788040475
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.0448126969307971
P/E ratio: 153.6310382751812
Shares outstanding: 526971060
Book value: -102719219.07879356
Market cap (USD): 550586054.4030809
Debt to equity: -2.688181847772324
Current ratio: 1.1000758329724678
Quick ratio: 0.63188912030335
Effective tax rate (%): -0.2341062764023489
Interest coverage ratio: 9.606690672551979
COGS to revenue (%): 85.76740003169483
Buyback yield (%): 0
Retained earnings: -233413829.78723404
Inventory turnover: 1.3929790229932593
Receivables turnover: 1.9008631685883624
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6134598448385118
Rule of 40 score: 0
Financial ratios for DIACABS.NS — quarterly report dated 2025-06-30
Total revenue: 35317446.75871753
Gross profit: 6842089.86660426
Operating income: 2763468.2892581327
Net income: 2352773.2272408144
Capital expenditures: 0
Depreciation & amortization: 853919.9625555816
Owner earnings: 3206693.189796396
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.6174818628598175
P/E ratio: 262.3691622247155
Shares outstanding: 526971060
Market cap (USD): 852366131.8020127
Effective tax rate (%): 0.13707883026064843
Interest coverage ratio: 6.398948708917008
COGS to revenue (%): 80.62688417611785
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -9.497325388832518
Rule of 40 score: -9.497325388832518
Financial ratios for DIACABS.NS — quarterly report dated 2025-09-30
Total revenue: 49417463.359639235
Gross profit: 9237711.38669673
Operating income: 4342593.010146561
Net income: 3126020.293122886
Capital expenditures: 0
Depreciation & amortization: 834261.5558060879
Net tangible assets: -80557655.01691094
Owner earnings: 3960281.848928974
Return on net tangible assets (%): -4.916083826046846
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.683314543404735
P/E ratio: 139.15184752606717
Shares outstanding: 526971060
Book value: -80557655.01691094
Market cap (USD): 887058049.2514092
Debt to equity: -0.8533722932478561
Current ratio: 2.5071456343236083
Quick ratio: 1.5427011377471302
Effective tax rate (%): 3.7412994046275885
Interest coverage ratio: 3.92340364851238
COGS to revenue (%): 81.30678760366835
Buyback yield (%): 0
Inventory turnover: 1.274858248487513
Receivables turnover: 1.4845421752075343
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1914407123428266
Revenue growth (%): 39.92365783758519
Rule of 40 score: 39.92365783758519
Financial ratios for DIACABS.NS — quarterly report dated 2025-12-31
Total revenue: 52810582.599977724
Gross profit: 12280851.063829787
Operating income: 6823838.698897182
Net income: 5538565.2222346
Capital expenditures: 0
Depreciation & amortization: 875660.0200512421
Owner earnings: 6414225.242285842
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.5378188704466973
P/E ratio: 68.02356173614538
Shares outstanding: 526971060
Market cap (USD): 810386040.2472987
Effective tax rate (%): 2.121757960529554
Interest coverage ratio: 5.519498306062135
COGS to revenue (%): 76.74547323809496
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 6.866235151822371
Rule of 40 score: 6.866235151822371
Financial ratios for DUOL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 106.11
Shares outstanding: 40237065
Market cap (USD): 4269554967.15
Buyback yield (%): 0.020329987707815005
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DUOL — annual report dated 2022-12-31
Total revenue: 369495000
Gross profit: 270064000
Operating income: -65195000
Net income: -59574000
Capital expenditures: 5562000
Operating cash flow: 53656000
Depreciation & amortization: 4870000
Net tangible assets: 529531000
Owner earnings: -60266000
Return on net tangible assets (%): -11.381014520396352
Buffett classification: The Gruesome
Stock price: 71.13
Shares outstanding: 40237065
Book value: 542078000
P/B ratio: 5.279798171942045
Market cap (USD): 2862062433.45
Debt to equity: 0.052402052841104045
Current ratio: 3.8356073193006393
Quick ratio: 3.8356073193006393
COGS to revenue (%): 26.909971718155862
R&D to revenue (%): 40.71611253196931
SG&A to revenue (%): 50.01826817683595
Free cash flow (dilution-adjusted): -30288000
Buyback yield (%): 0
Retained earnings: -230488000
Receivables turnover: 7.9073574730354395
Capitalized R&D asset: 150444000
ROCI (R&D-adjusted, %): 4.902203135365385
FCF margin (%): -8.197133926034182
Rule of 40 score: -8.197133926034182
Financial ratios for DUOL — annual report dated 2023-12-31
Total revenue: 531109000
Gross profit: 389004000
Operating income: -13259000
Net income: 16067000
Capital expenditures: 3191000
Operating cash flow: 153614000
Depreciation & amortization: 7095000
Net tangible assets: 635456000
Owner earnings: 19971000
Return on net tangible assets (%): 3.142782505791117
Buffett classification: The Gruesome
Stock price: 226.85
P/E ratio: 568.1071883519014
Shares outstanding: 40237065
Book value: 655501000
P/B ratio: 13.924888284304675
Market cap (USD): 9127778195.25
Debt to equity: 0.03217996616328579
Current ratio: 3.2369178185908667
Quick ratio: 3.2369178185908667
Effective tax rate (%): 9.619170838724195
COGS to revenue (%): 26.756277901523042
R&D to revenue (%): 36.59361825915208
SG&A to revenue (%): 39.14657819769577
Free cash flow (dilution-adjusted): 44709000
Buyback yield (%): 0
Retained earnings: -214421000
Receivables turnover: 5.969193593706097
Capitalized R&D asset: 295149480
ROCI (R&D-adjusted, %): 6.808477059730763
Rosenberg metric: 0.7905931775278509
FCF margin (%): 8.418046013153608
Revenue growth (%): 43.73915749874829
Rule of 40 score: 52.1572035119019
Financial ratios for DUOL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 282.02
Shares outstanding: 40237065
Market cap (USD): 11347657071.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DUOL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 324.23
Shares outstanding: 40237065
Market cap (USD): 13046063584.95
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DUOL — annual report dated 2024-12-31
Total revenue: 748024000
Gross profit: 544379000
Operating income: 62595000
Net income: 88574000
Capital expenditures: 12116000
Operating cash flow: 285513000
Depreciation & amortization: 10854000
Net tangible assets: 794113000
Owner earnings: 87312000
Return on net tangible assets (%): 10.994908785021778
Capex to operating income (%): 19.356178608515055
Buffett classification: The Great
Stock price: 324.23
P/E ratio: 147.28999012069005
Shares outstanding: 40237065
Book value: 824550000
P/B ratio: 15.822040609969074
Market cap (USD): 13046063584.95
Debt to equity: 0.06628585288945485
Current ratio: 2.608969971413752
Quick ratio: 2.608969971413752
Effective tax rate (%): 13.422477665044083
COGS to revenue (%): 27.224393869715406
R&D to revenue (%): 31.455942590077324
SG&A to revenue (%): 32.951616525672975
Free cash flow (dilution-adjusted): 153896000
Buyback yield (%): 0
Retained earnings: -125847000
Receivables turnover: 5.800884063590539
Capitalized R&D asset: 415160360
ROCI (R&D-adjusted, %): 8.073822199051442
Rosenberg metric: 0.7994515106610686
FCF margin (%): 20.57367143300215
Revenue growth (%): 40.84189874394898
Rule of 40 score: 61.415570176951135
Financial ratios for DUOL — quarterly report dated 2025-03-31
Total revenue: 230743000
Gross profit: 164096000
Operating income: 23594000
Net income: 35135000
Capital expenditures: 1309000
Operating cash flow: 105631000
Depreciation & amortization: 3590000
Net tangible assets: 864416000
Owner earnings: 37416000
Return on net tangible assets (%): 4.328471476696405
Capex to operating income (%): 5.548020683224548
Buffett classification: The Great
Stock price: 310.54
P/E ratio: 88.90862505407715
Shares outstanding: 40237065
Book value: 893826000
P/B ratio: 13.97947493706829
Market cap (USD): 12495218165.1
Debt to equity: 0.06101075600844012
Current ratio: 2.6836023191084415
Quick ratio: 2.6836023191084415
Effective tax rate (%): -0.3570408454727221
COGS to revenue (%): 28.883649774857744
R&D to revenue (%): 30.505800826027222
SG&A to revenue (%): 30.385320464759495
Free cash flow (dilution-adjusted): 71994000
Buyback yield (%): 0
Retained earnings: -90712000
Receivables turnover: 2.020817459691898
Capitalized R&D asset: 70390000
ROCI (R&D-adjusted, %): 6.920229376809077
FCF margin (%): 31.200946507586362
Rule of 40 score: 31.200946507586362
Financial ratios for DUOL — quarterly report dated 2025-06-30
Total revenue: 252265000
Gross profit: 182581000
Operating income: 33363000
Net income: 44781000
Capital expenditures: 1198000
Operating cash flow: 90675000
Depreciation & amortization: 3440000
Net tangible assets: 946569000
Owner earnings: 47023000
Return on net tangible assets (%): 4.967730825750684
Capex to operating income (%): 3.590804184275995
Buffett classification: The Great
Stock price: 410.02
P/E ratio: 206.44178126157465
Shares outstanding: 40237065
Book value: 977031000
P/B ratio: 16.88585253825109
Market cap (USD): 16498001391.3
Debt to equity: 0.09604915299514549
Current ratio: 2.8087351474278877
Quick ratio: 2.8087351474278877
Effective tax rate (%): 3.5931108719052745
COGS to revenue (%): 27.623332606584345
R&D to revenue (%): 29.203417041603075
SG&A to revenue (%): 29.94787227716885
Free cash flow (dilution-adjusted): 51732000
Buyback yield (%): 0
Retained earnings: -45931000
Receivables turnover: 2.2340350162505866
Capitalized R&D asset: 120831300
ROCI (R&D-adjusted, %): 4.950724714521463
Rosenberg metric: 0.2626083250461713
FCF margin (%): 20.50700652092046
Revenue growth (%): 9.327260198575905
Rule of 40 score: 29.834266719496362
Financial ratios for DUOL — quarterly report dated 2025-09-30
Total revenue: 271713000
Gross profit: 196911000
Operating income: 35159000
Net income: 292195000
Capital expenditures: 4862000
Operating cash flow: 84239000
Depreciation & amortization: 3553000
Net tangible assets: 1244236000
Owner earnings: 290886000
Return on net tangible assets (%): 23.378683786677126
Capex to operating income (%): 13.82860718450468
Buffett classification: The Great
Stock price: 321.84
P/E ratio: 34.801166855051314
Shares outstanding: 40237065
Book value: 1307539000
P/B ratio: 9.904023512568267
Market cap (USD): 12949896999.599998
Debt to equity: 0.07132253798930663
Current ratio: 2.8214492095595824
Quick ratio: 2.8214492095595824
Effective tax rate (%): -529.066287756464
COGS to revenue (%): 27.529783263958663
R&D to revenue (%): 30.439103024146803
SG&A to revenue (%): 29.09135742492998
Free cash flow (dilution-adjusted): 41791000
Buyback yield (%): 0
Retained earnings: 246264000
Receivables turnover: 2.0220502325581395
Capitalized R&D asset: 155294600
ROCI (R&D-adjusted, %): 2.7163454773557776
Rosenberg metric: 0.19451608524501154
FCF margin (%): 15.38056699532227
Revenue growth (%): 7.709353259469209
Rule of 40 score: 23.08992025479148
Financial ratios for DUOL — annual report dated 2025-12-31
Total revenue: 1037589000
Gross profit: 749457000
Operating income: 135570000
Net income: 414065000
Capital expenditures: 18096000
Operating cash flow: 387823000
Depreciation & amortization: 14391000
Net tangible assets: 1283362000
Owner earnings: 410360000
Return on net tangible assets (%): 31.975389640646988
Capex to operating income (%): 13.348085859703474
Buffett classification: The Great
Stock price: 175.5
P/E ratio: 17.054339071160324
Shares outstanding: 40237065
Book value: 1347006000
P/B ratio: 5.242445028084507
Market cap (USD): 7061604907.5
Debt to equity: 0.06962032834300663
Current ratio: 2.6065702860211775
Quick ratio: 2.6065702860211775
Effective tax rate (%): -126.99687517131737
COGS to revenue (%): 27.76937689200637
R&D to revenue (%): 29.522575894694334
SG&A to revenue (%): 29.642180092502908
Free cash flow (dilution-adjusted): 222987000
Buyback yield (%): 0
Retained earnings: 288218000
Receivables turnover: 5.865597476454826
Capitalized R&D asset: 528108820
ROCI (R&D-adjusted, %): 9.982448437471216
Rosenberg metric: 0.8715671191425342
FCF margin (%): 21.490879336615944
Revenue growth (%): 38.710656342577245
Rule of 40 score: 60.201535679193185
Financial ratios for DUOL — quarterly report dated 2025-12-31
Total revenue: 282868000
Gross profit: 205869000
Operating income: 43454000
Net income: 41954000
Capital expenditures: 10727000
Operating cash flow: 107278000
Depreciation & amortization: 3808000
Net tangible assets: 1283362000
Owner earnings: 35035000
Return on net tangible assets (%): 2.7299390195439788
Capex to operating income (%): 24.685874718092695
Buffett classification: The Great
Stock price: 175.5
P/E ratio: 17.054339071160324
Shares outstanding: 40237065
Book value: 1347006000
P/B ratio: 5.242445028084507
Market cap (USD): 7061604907.5
Debt to equity: 0.06962032834300663
Current ratio: 2.6065702860211775
Quick ratio: 2.6065702860211775
Effective tax rate (%): 23.021595934019558
COGS to revenue (%): 27.220823847165466
R&D to revenue (%): 28.12477904888499
SG&A to revenue (%): 29.292461501477725
Free cash flow (dilution-adjusted): 57470000
Buyback yield (%): 0
Retained earnings: 288218000
Receivables turnover: 1.5990819360747115
Capitalized R&D asset: 159280790
ROCI (R&D-adjusted, %): 2.772308732250526
Rosenberg metric: 0.10831005839892634
FCF margin (%): 20.316896927188655
Revenue growth (%): 4.105434778608311
Rule of 40 score: 24.422331705796964
Financial ratios for ECOB.L — annual report dated 2023-12-31
Total revenue: 176648.10126582277
Gross profit: 27491.139240506327
Operating income: -1753603.7974683545
Net income: -3215307.594936709
Capital expenditures: 687584.8101265823
Operating cash flow: -797221.5189873418
Depreciation & amortization: 263225.3164556962
Net tangible assets: 1530305.0632911392
Owner earnings: -3639667.088607595
Return on net tangible assets (%): -237.8393155662683
Buffett classification: The Gruesome
Stock price: 0.0017721518987341774
Shares outstanding: 140987383
Book value: 14102035.443037976
P/B ratio: 0.017717375586682522
Market cap (USD): 249851.05848101267
Debt to equity: 0.474162630980284
Current ratio: 1.442790412925501
Quick ratio: 0.551307658697959
Interest coverage ratio: -4.343951660949347
COGS to revenue (%): 84.43734235267142
SG&A to revenue (%): 678.48113964687
Free cash flow (dilution-adjusted): -1493600
Buyback yield (%): 0
Retained earnings: -3639592.405063291
Inventory turnover: 0.056508684624337675
Receivables turnover: 1.7714365503497125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.421642174843724
FCF margin (%): -845.5228158679203
Rule of 40 score: -845.5228158679203